Autoimmune Disease Diagnostics Market and Forecast to 2030

The global autoimmune disease diagnostics market was valued at USD 6,583 Million in 2024, and the market is projected to reach USD 10,423 Million by 2030. Autoimmune diseases are characterized by an abnormal immune response in which the body produces antibodies that mistakenly attack its own cells and tissues, leading to the deterioration and destruction of healthy tissue. There are more than 80 known types of autoimmune diseases worldwide, including well-known conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ, and Non-organ specific (or systemic), where the autoantibodies attack multiple organ systems. For example, in Hashimoto’s thyroiditis, autoantibodies specifically target and damage the thyroid gland. In contrast, systemic autoimmune diseases involve multiple organ systems. A classic example is systemic lupus erythematosus (SLE), in which autoantibodies can affect a wide range of tissues and organs throughout the body.

The increasing incidence of conditions like rheumatoid arthritis and Hashimoto’s thyroiditis, coupled with supportive government policies, is expected to significantly influence the growth of the autoimmune disease diagnostics market. According to the American Autoimmune Related Diseases Association, more than 50 million people in the United States are currently affected by autoimmune disorders. This number is projected to rise in the coming years. Consequently, the growing need for accurate and advanced diagnostic techniques, alongside the rising prevalence of these diseases, is anticipated to propel market expansion over the forecast period.

1. Autoimmune Disease Diagnostics Market
2024-2030
A comprehensive analysis of market size, growth projections,
segmentation, regional trends, and key industry players in the global
autoimmune diagnostics landscape
September2025
ApeloConsulting

2. MarketOverview&Size
Key Market Metrics
Market valued at USD 6,583 Million in 2024
Projected to reach USD 10,423 Million by 2030
Robust 7.9% CAGR during theforecast period
Growthdrivenbyincreasingprevalenceof
autoimmuneconditionsandtechnological
advancements
Market Growth Projection (2024-2030)
ApeloConsultingPage2

3. Understanding Autoimmune Diseases
80+ known types of autoimmune diseases
worldwide
Abnormal immune response where the body's
immune system attacks its own cells and tissues
Results in deterioration and destruction of healthy
tissue
Common examples: Hashimoto's thyroiditis (organ-
specific) and Systemic Lupus Erythematosus
(systemic)
Two Major Categories
Organ-Specific
ApeloConsultingPage3
Autoantibodiestargeta
specificorgan
Example:Hashimoto's
thyroiditisattacksthyroid
gland
Type1diabetes,Multiple
sclerosis
Systemic
Autoantibodiesattack
multipleorgansystems
Example:SLEaffects tissues
throughoutbody
Rheumatoidarthritis,
Ankylosingspondylitis

4. Market Drivers
KeyGrowthFactors
50+millionAmericanscurrentlyaffectedby
autoimmunedisorders
RisingglobalprevalenceacrossAsia-Pacific,Europe,
anddevelopingregions
Supportivegovernmentpoliciesandincreased
healthcarefunding
Growingdemandforadvanceddiagnostic
techniqueswithhigheraccuracy
Global Autoimmune Disease Prevalence
Trend
ApeloConsultingPage4

5. Recent Market Developments
KeyInnovations
Recent breakthroughs in autoimmune
diagnostic technologies are transforming
patient care and market landscape
Theseinnovationsrepresent
significant advancementsin
precisionmedicinefor autoimmune
diseasemanagement
Predicta Biosciences
Launched its first molecular diagnostic product to optimize the
prognosis of multiple myeloma, bringing advanced precision
oncology to autoimmune diagnostics
FEBRUARY2025
Biocon Biologics
Launched YESINTEK (ustekinumab-kfce), a biosimilar option to
Stelara in the US market for Crohn's disease, ulcerative colitis,
plaque psoriasis, and psoriatic arthritis
DECEMBER 2024
Quest Diagnostics
Introduced a revolutionary autoimmune disease diagnostic
service using AI algorithms to analyze test results in real
time, providing clinicians with instant feedback on patient
status
Page5 ApeloConsulting
APRIL2025

6. Disease Segmentation
Types of Autoimmune Diseases
Autoimmune diseases are categorized into two
general groups based on their impact on the body:
Organ-specific: Autoantibodies target a
specific organ
Systemic: Autoantibodies attack
multiple organ systems
Localized
Autoimmune Diseases
Multiple Sclerosis
Highest market share in
localized segment (2024)
Type 1 Diabetes Affects
pancreatic islet cells
Hashimoto's Thyroiditis
Targets the thyroid gland
Inflammatory Bowel
Disease
Affects the digestive tract
SystemicAutoimmune
Diseases
Rheumatoid Arthritis
Over 50% of systemic market
share (2024)
Systemic Lupus
Erythematosus Affects
multiple body systems
SystemicSclerosis
Causesskinandtissue
hardening
Ankylosing Spondylitis
Primarily affects the spine
Localizedvs
Systemic
Market Share
MultipleSclerosis
(HighestShare)
ApeloConsultingPage6
RheumatoidArthritis
(>50%)

7. Test Types Analysis
Key Diagnostic Methods
Autoantibody Tests: Captured largest market
share in 2024; used for diagnosing various
autoimmune disorders
Antinuclear Antibody (ANA) Tests: Critical for
diagnosing SLE, rheumatoid arthritis in
primary care and specialty settings
Complete Blood Count (CBC): Essential
for diagnosing SLE, Idiopathic
Thrombocytopenic Purpura, and
Multiple Sclerosis
OtherKeyTests:ESR,CRP,
Urinalysis,andComprehensive
Metabolic Panel Tests for
comprehensivediagnosis
Autoimmune Diagnostic Test Types Market
Share (2024)
ApeloConsultingPage7

8. Regional Market Analysis
Key Regional Insights
North America: Largest market share, driven
by high prevalence rates and advanced
healthcare infrastructure
Europe: Second-largest market, with
multiple sclerosis prevalence at 83 per
100,000 population
Asia-Pacific: Fastest-growing region, driven
by large population, increasing disease
prevalence, and healthcare investments
South America & Middle East/Africa:
Emerging markets with significant
growth potential
Regional Market Share Distribution (2024)
ApeloConsultingPage8

9. Key MarketPlayers
Leading Diagnostics Companies
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics
bioMerieux SA
EUROIMMUN AG
Bio-Rad Laboratories
Quest Diagnostics
Thermo Fischer Scientific Inc.
Danaher Corporation
Market Positioning Matrix
ApeloConsultingPage9

10. Market Forecast & Conclusion
Market Expected to Reach
USD 10,423 Million by 2030
Strong Growth Drivers
Rising prevalence of autoimmune conditions worldwide
Technological innovation in diagnostic techniques
Supportive government policies and healthcare investments
Expanding awareness and early disease detection initiatives
Stakeholder Opportunities
Investment in AI-powered diagnostic tools
Expansion into emerging markets in Asia-Pacific region
Strategic partnerships for comprehensive diagnostic solutions
Development of point-of-care testing solutions
Market Growth Trend (2024-2030)
Page10 ApeloConsulting